Clearpoint Neuro Inc
NASDAQ:CLPT

Watchlist Manager
Clearpoint Neuro Inc Logo
Clearpoint Neuro Inc
NASDAQ:CLPT
Watchlist
Price: 11.835 USD 6.72% Market Closed
Market Cap: 326.4m USD
Have any thoughts about
Clearpoint Neuro Inc?
Write Note

Clearpoint Neuro Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Clearpoint Neuro Inc
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Clearpoint Neuro Inc
NASDAQ:CLPT
Other Current Liabilities
$1.3m
CAGR 3-Years
42%
CAGR 5-Years
3%
CAGR 10-Years
-9%
Becton Dickinson and Co
NYSE:BDX
Other Current Liabilities
$6.8B
CAGR 3-Years
238%
CAGR 5-Years
117%
CAGR 10-Years
67%
Boston Scientific Corp
NYSE:BSX
Other Current Liabilities
$1B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Other Current Liabilities
$699m
CAGR 3-Years
5%
CAGR 5-Years
19%
CAGR 10-Years
3%
Abbott Laboratories
NYSE:ABT
Other Current Liabilities
$1.6B
CAGR 3-Years
10%
CAGR 5-Years
20%
CAGR 10-Years
-3%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Current Liabilities
$590.6m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
10%
No Stocks Found

Clearpoint Neuro Inc
Glance View

Market Cap
326.5m USD
Industry
Health Care

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 80 full-time employees. The company went IPO on 2019-07-03. The Company’s product platforms include SmartFlow Cannula and ClearPoint Navigation System Software. The SmartFlow Cannula is being utilized in approved combination product clinical and preclinical studies by pharmaceutical companies and academic research customers for various research and clinical trials in connection with delivery of therapeutic agents. The ClearPoint Navigation System Software is a software for surgical planning, navigation to target, and device delivery. The Company’s software and MRI-compatible workstation coordinate with the scanner to effectively utilize intraprocedural MR images. This provides real-time navigational instruction for the neurosurgeon to reach the desired anatomical target with a high degree of precision.

CLPT Intrinsic Value
6.784 USD
Overvaluation 43%
Intrinsic Value
Price

See Also

What is Clearpoint Neuro Inc's Other Current Liabilities?
Other Current Liabilities
1.3m USD

Based on the financial report for Sep 30, 2024, Clearpoint Neuro Inc's Other Current Liabilities amounts to 1.3m USD.

What is Clearpoint Neuro Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-9%

Over the last year, the Other Current Liabilities growth was 6%. The average annual Other Current Liabilities growth rates for Clearpoint Neuro Inc have been 42% over the past three years , 3% over the past five years , and -9% over the past ten years .

Back to Top